BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24439676)

  • 1. Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia.
    Thaler J; Pabinger I; Sperr WR; Ay C
    Thromb Res; 2014 Mar; 133(3):303-5. PubMed ID: 24439676
    [No Abstract]   [Full Text] [Related]  

  • 2. Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia.
    Gheldof D; Chatelain C; Dogné JM; Mullier F
    Thromb Res; 2014 Jul; 134(1):213-4. PubMed ID: 24861693
    [No Abstract]   [Full Text] [Related]  

  • 3. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
    Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
    J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis.
    van Es N; Bleker S; Sturk A; Nieuwland R
    Semin Thromb Hemost; 2015 Oct; 41(7):718-27. PubMed ID: 26408926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
    Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
    Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
    Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
    Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
    Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism.
    Garcia Rodriguez P; Eikenboom HC; Tesselaar ME; Huisman MV; Nijkeuter M; Osanto S; Bertina RM
    Thromb Res; 2010 Oct; 126(4):345-9. PubMed ID: 20708219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute massive intravascular hemolysis and disseminated intravascular coagulation.
    Atichartakarn V; Jootar S; Pathepchotiwong K; Srichaikul T
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):338-41. PubMed ID: 390722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor released from leukemic cells.
    Kubota T; Andoh K; Sadakata H; Tanaka H; Kobayashi N
    Thromb Haemost; 1991 Jan; 65(1):59-63. PubMed ID: 2024239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
    Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
    Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In-vitro "thromboplastic" activity of leukocytes and intravascular blood coagulation in leukemias].
    Gouault-Heilmann M; Varet B; Romano C; Josso F
    Pathol Biol (Paris); 1972 Dec; ():Suppl:56-64. PubMed ID: 4574606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood platelets, leukocytes and disseminated intravascular coagulation].
    Onozawa Y; Yamazaki H
    Rinsho Byori; 1985 Jun; Spec No 63():5-16. PubMed ID: 3900486
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis.
    Gralnick HR; Tan HK
    Hum Pathol; 1974 Nov; 5(6):661-73. PubMed ID: 4607877
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of tissue factor antigen and activity on the surface of leukemic cells.
    Tanaka M; Yamanishi H
    Leuk Res; 1993 Feb; 17(2):103-11. PubMed ID: 8429686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
    Sakuragawa N; Takahashi K; Hoshiyama M; Jimbo C; Matsuoka M
    Thromb Res; 1976 Mar; 8(3):263-73. PubMed ID: 1083568
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated levels of tissue factor pathway inhibitor in acute non-lymphoblastic leukemia patients with disseminated intravascular coagulation.
    Velasco F; Lopez-Pedrera C; Borrell M; Fontcuberta J; Torres A
    Blood Coagul Fibrinolysis; 1997 Jan; 8(1):70-2. PubMed ID: 9105641
    [No Abstract]   [Full Text] [Related]  

  • 19. [The tissue factor activity in plasma in patient with DIC].
    Iijima K; Fukuda C; Nakamura K
    Rinsho Byori; 1990 Jul; Suppl 86():142-8. PubMed ID: 2232235
    [No Abstract]   [Full Text] [Related]  

  • 20. Utility of activated partial thromboplastin time waveform analysis for identification of sepsis and overt disseminated intravascular coagulation in patients admitted to a surgical intensive care unit.
    Dempfle CE; Lorenz S; Smolinski M; Wurst M; West S; Houdijk WP; Quintel M; Borggrefe M
    Crit Care Med; 2004 Feb; 32(2):520-4. PubMed ID: 14758173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.